Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamidronate for Steroid-Induced Osteoporosis in Children
NCT00022841Phase 2Terminated
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of pamidronate in glucocorticoid-induced osteoporosis (GIOP), sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases. Status: terminated.
02
Drugs
pamidronate
03
Conditions
glucocorticoid-induced osteoporosis (GIOP)
Beyond the preview
Go deeper on NCT00022841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00022841.